Skip to main content
SpringerLink
Log in

Therapeutic strategies for the inherited neuropathies

  • Review Article
  • Published:
NeuroMolecular Medicine Aims and scope Submit manuscript

Abstract

More than 30 genetic causes have been identified for the inherited neuropathies collectively referred to as Charcot-Marie-Tooth (CMT) disease. Previous therapies for CMT were limited to traditional approaches such as rehabilitation medicine, ambulation aids, and pain management. Identification of the genes causing CMT has led to improved genetic counseling and assistance in family planning. Identification of these genes is beginning to delineate common molecular pathways in multiple forms of CMT that can be exploited in future molecular therapies. Scientifically based clinical trials for CMT are currently being implemented. Techniques of gene therapy are advancing to the point that they may become feasible options for patients with CMT and other neurodegenerative diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Acsadi G., Anguelov R. A., Yang H., et al. (2002) Increased survival and function of SOD-1 after GDNF gene transfe. Hum. Gene. Ther. 13, 1047–1059.

    PubMed  CAS  Google Scholar 

  • Acsadi G., Massie B., and Jani A. (1995) Adenovirus-mediated gene transfer into striated muscle. J. Mol. Med. 73(4), 165–180.

    PubMed  CAS  Google Scholar 

  • Antonellis A., Ellsworth R. E., Sambuughin N., et al. (2003) Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 72(5), 1293–1239.

    PubMed  CAS  Google Scholar 

  • Apfel S. C. (2002) Is the therapeutic application of neurotrophic factors dead? Ann. Neurol. 51(1), 8–11.

    PubMed  Google Scholar 

  • Apfel S. C. (2002) Neurve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int. Rev. Neurobiol. 50, 393–413.

    PubMed  CAS  Google Scholar 

  • Arroyo E. J. and Scherer S. S. (2000) On the molecular architecture of myelinated fibers. Histochem. Cell. Biol. 113(1), 1–18.

    PubMed  CAS  Google Scholar 

  • Arruda V. R., Stedman H. H., Nichols T. C., et al. (2005) Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model. Blood 105(9), 3458–3464. Epub 2004 Oct 12.

    PubMed  CAS  Google Scholar 

  • Azzouz M., Ralph G. S., Storkebaum E., et al. (2004) VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature, 429(6990), 413–417.

    PubMed  CAS  Google Scholar 

  • Bao J., Wolpowitz D., Role L. W., and Talmage D. A. (2003) Back signaling by the Nrg-1 intracellular domain. J. Cell Biol. 161(6), 1133–1141.

    PubMed  CAS  Google Scholar 

  • Bennett C. L., Shirk A. J., Huynh H. M., et al. (2004) SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve. Ann. Neurol. 55(5), 713–720.

    PubMed  CAS  Google Scholar 

  • Bergoffen J., Scherer S. S., Wang S., et al., (1993) Conexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262(5142), 12039–2042.

    Google Scholar 

  • Berkner K. L. (1992) Expression of heterologous sequences in adenoviral vectors. Curr. Top Microbiol. Immunol. 158, 39–66.

    PubMed  CAS  Google Scholar 

  • Bhattacharya R., Kang-Decker N., Hughes D. A., et al. (2005) Regulatory role of dynamin-2 in VEGFR-2/ KDR-mediated endothelial signaling. FASEB J. 19, 1692–1694.

    PubMed  CAS  Google Scholar 

  • Bird T. D., Ott J., and Giblett E. R. (1982) Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am. J. Hum. Genet. 34(3), 388–394.

    PubMed  CAS  Google Scholar 

  • Blankinship M. J., Gregorevic P., Allen J. M., et al., (2004) Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol. Ther. 10(4), 671–678.

    PubMed  CAS  Google Scholar 

  • Blomer U., Naldini L., Kafri T., Trono D., Verma I. M., and Gage F. H. (1997) Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71(9) 6641–6649.

    PubMed  CAS  Google Scholar 

  • Bomont P., Cavalier L., Blondeau F., et al. (2000) The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat. Genet. 26(3), 370–374.

    PubMed  CAS  Google Scholar 

  • Boulis N. M., Turner D. E., Dice J. A., Bhatia V., and Feldman E. L. (1999) Characterization of adenoviral gene expression in spinal cord after remote vector delivery. Neurosurgery 45(1), 131–137. discussion 137, 138.

    PubMed  CAS  Google Scholar 

  • Bunge M. B., Williams A. K., Wood P. M., Uitto J., and Jeffrey J. J. (1980) Comparison of nerve cell and nerve cell plus Schwann cell cultures, with particular emphasis on basal lamina and collagen formation. J. Cell Biol. 84(1) 184–202.

    PubMed  CAS  Google Scholar 

  • Bunge R. P. (1987) Tissue culture observations relevant to the study of axon-Schwann cell interactions during peripheral nerve development and repair. J. Exp. Biol. 132, 21–34.

    PubMed  CAS  Google Scholar 

  • Cao H., Koehler D. R., and Hu J. (2004) Adenoviral vectors for gene replacement therapy. Viral Immunol. 17(3), 327–333.

    PubMed  CAS  Google Scholar 

  • Chance P. F., Alderson M. K., Leppig K. A., et al. (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72(1), 143–151.

    PubMed  CAS  Google Scholar 

  • Chao H., Liu Y., Rabinowitz Li C., Samulski R. J., and Walsh C. E. (2000) Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther. 2(6), 619–623.

    PubMed  CAS  Google Scholar 

  • Charcot J. and Marie P. (1886) Sur une forme particulaire d'atrophie musculaire progressive souvent familial debutant par les pieds et les jamber et atteingnant plus tard les mains. Rev. Med. 6, 97–138.

    Google Scholar 

  • Chen Y. Z., Bennett C. L., Huynh H. M., et al. (2004) DNA/RNA Helicase Gene mutations in a Form of Juvenile Amyotrophic Lateral Sclrosis (ALS4). Am. J. Hum. Genet. 74(6), 1128–1135. Epub 2004 Apr 21.

    PubMed  CAS  Google Scholar 

  • Chetlin R. D., Gutmann L., Tarnopolsky M. A., Ullrich I. H., and Yeater R. A. (2004a) Resistance training effectiveness in patients with Charcot-Marie-Tooth disease, recommendations for exercise prescription. Arch. Phys. Med. Rehabil. 85(8), 1217–1223.

    Google Scholar 

  • Chetlin R. D., Gutmann L., Tarnopolsky M. A., Ullrich I. H., and Yeater R. A. (2004b) Resistance training exercise and creatine in patients with charcot-Marie-Tooth disease. Muscle Nerve 30(1), 69–76.

    CAS  Google Scholar 

  • Chiorini J. A., Afione S., and Kotin R. M. (1999) Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes. J. Virol. 73(5, 4293–4298.

    PubMed  CAS  Google Scholar 

  • Cohen J. A., Cutter G. R., Fischer J. S., et al. (2001). Use of the multiple sclerosis functional composite as an out come measure in a phase 3 clinicaltrial. Arch. Neurol. 58(6) 961–967.

    PubMed  CAS  Google Scholar 

  • Colby J., Nicholson R., Dickson K. M., et al., (2000) PMP22 Carrying the Trembler or Trembler-J Mutation Is Intracellularly Retained in Myelinating Schwann Cells. Neurobiol. Dis. 7(6 PtB), 561–573.

    PubMed  CAS  Google Scholar 

  • Cornblath D. R., Chaudhry V., Carter K., et al. (1999) Total neuropathy score, validation and reliability study. Neurology 53(8) 1660–1664.

    PubMed  CAS  Google Scholar 

  • De Vos A., Sermon K., De Rijcke M., et al., (2003) Preim-plantation genetic diagnosis for Charcot-Marie-Tooth disease type 1A. Mol. Hum. Reprod. 9(7), 429–435.

    PubMed  Google Scholar 

  • de Waegh S. and Brady S. T. (1990) Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions. J. Neurosci. 10(6) 1855–1865.

    PubMed  Google Scholar 

  • Dejerine H. and Sottas J. (1893) Sur la nevritte interstitielle, hypertrophique et progressive de l'enfance. CR Soc. Biol. Paris 45, 63–96.

    Google Scholar 

  • Ding J., Liu J. J., Kowal A. S., et al. (2002) Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin. J. Cell Biol. 158(3) 427–433. Epub 2002 Jul 29.

    PubMed  CAS  Google Scholar 

  • Duan D., Yan Z., Yue Y., Ding W., and Engelhardt J. F. (2001) Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 cor-relates with myoblast differentiation. J. Virol. 75(16), 7662–7671.

    PubMed  CAS  Google Scholar 

  • Dyck P. J. and Lambert E. H. (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch. Neurol. 18(6) 603–618.

    PubMed  CAS  Google Scholar 

  • Dyck P. J. and Lambert E. H. (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch. Neurol. 18(6) 619–625.

    PubMed  CAS  Google Scholar 

  • Dyck P. J., Litchy W. J., Lehman K. A., Hokanson J. L., Low P. A., and O'Brien P. C. (1995) Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 45(6) 1115–1121.

    PubMed  CAS  Google Scholar 

  • Dyck P. J., Sherman W. R., Hallcher L. M., et al. (1980) Human Diabetic Endoneurial Sorbitol, Fructose, and myo-Inositol Related to Sural Nerve Morphometry. Ann. Neurol. 8, 590–596.

    PubMed  CAS  Google Scholar 

  • Federoff H. J., Geschwind M. D., Geller A. I., and Kessler J. A. (1992) Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector preventseffects of axotomy on sympathetic ganglia. Proc. Natl. Acad. Sci. USA 89(5) 1636–1640.

    PubMed  CAS  Google Scholar 

  • Feltri M. L., Scherer S. S., Wrabetz L., Kamholz J., and Shy M. E. (1992) Mitogen-expanded Schwann cells retain the capacity to myelinate regenerating axons after transplantation into rat sciatic nerve. Proc. Natl. Acad. Sci. USA 89(18) 8827–8831.

    PubMed  CAS  Google Scholar 

  • Fortun J., Dunn W. A., Jr., Joy S., Li, J., and Notterpek L. (2003) Emerging role for autophagy in the removal of aggresomes in Schwann cells. Neurosci. 23(33), 10,672–10,680.

    CAS  Google Scholar 

  • Fortun J., Li J., Go J., Fenstermaker A., Fletcher B. S., and Notterpek L. (2005) Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. J. Neurochem. 92(6) 1531–1541.

    PubMed  CAS  Google Scholar 

  • Grandis M. and Shy M. E. Peripheral Neuropathies. In: Rackel R. and Bope E. T. (eds) Conn's Current Therapy 2006. Elsevier, Philadelphia, in press.

  • Gravel C., Gotz R., Lorrain A., and Sendtner M., (1997) Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nat. Med. 3(7) 765–770.

    PubMed  CAS  Google Scholar 

  • Griffin J. W. and Watson D. F., (1988) Axonal transport in neurological disease. Ann. Neurol. 23(1) 3–13.

    PubMed  CAS  Google Scholar 

  • Crimm D. (2002) Production methods for gene transfer vectors based on a deno-associated virus serotypes. Methods 28(2) 146–157.

    Google Scholar 

  • Grimm D., Kay M. A., and Kleinschmidt J. A. (2003) Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol. Ther. 7(6) 839–850.

    PubMed  CAS  Google Scholar 

  • Grimm D., Zhou S., Nakai H., et al. (2003) Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. Blood 102(7) 2412–2419. Epub 2003 Jun 05.

    PubMed  CAS  Google Scholar 

  • Guenard V., Schweitzer B., Flechsig E. (et al.) (1999) Effective gene transfer of lacZand P0 into schwann cells of P0-deficient mice. Glia 25(2), 165–178.

    PubMed  CAS  Google Scholar 

  • Gurunathan S., David D., and Gerst J. E. (2002) Dynamin and clathrin are required for the biogenesis of a distinct class of secretory vesicles in yeast. EMBO J. 21(4) 602–614.

    PubMed  CAS  Google Scholar 

  • Hahn A., Ciskind C., Krajewski K., Lewis R. and Shy M. E. (2005) Genotype-Phenotype Correlations in CMTX1 (Abstract). J. Peripheral Nervous System 10(Suppl. 1) 31, 32.

    Google Scholar 

  • Harding A. E. and Thomas P. K. (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103(2) 259–280.

    PubMed  CAS  Google Scholar 

  • Harding A. E. and Thomas P. K. (1980) Genetic aspects of hereditary motor and sensory neuropathy types I and II. J. Med. Genet. 17(5), 329–336.

    PubMed  CAS  Google Scholar 

  • Harrison R. G. (1924) Neuroblast versus sheath cell in the development of peripheral nerves. J. Comp. Neurol. 37, 123–194.

    Google Scholar 

  • Hayasaka K., Himoro M., Sato W., et al. (1993) Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat. Genet. 5(1) 31–34.

    PubMed  CAS  Google Scholar 

  • hendriks W. T., Ruitenberg M. J., Blitis B., Boer G. J. and Verhaagen J. et al (2004) Viral vector-mediated gene transfer of neurotrophins to promote regene-ration of the injured spinal cord. Prog. brain Res. 146, 451–476.

    PubMed  CAS  Google Scholar 

  • Himes B. T., Liu Y., Solowska J. M., Snyder E. Y., Fischer I. and Tessler A. (2001) Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats. J. Neurosci. Res. 65(6), 549–564.

    PubMed  CAS  Google Scholar 

  • Hoke A., Ho T., Crawford T. O., Lebel C., Hilt D., and Griffin J. W., (2003) Glial cell line-derived neurotrophic factor alters axon schwann cell units and promotes myelination in unmyelinated nerve fibers. J. Neurosci. 23(2), 561–567.

    PubMed  CAS  Google Scholar 

  • Huxley C., Passage E., Manson A., et al. (1996) Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. mol. Genet. 5(5), 563–569.

    PubMed  CAS  Google Scholar 

  • Huxley C., Passage E., Robertson A. M., et al. (1998) Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum. Mol. Genet. 7(3, 449–458.

    PubMed  CAS  Google Scholar 

  • Inoue K., Khajavi M., Ohyama T., et al., (2004) Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat. Genet. 36(4) 361–369. Epub 2004 Mar 7.

    PubMed  CAS  Google Scholar 

  • Jani A., Menichella D., Jiang H., et al., (1999) Modulation of cell-mediated immunity prolongs adenovirus-mediated transgene expression in sciatic nerve. Hum. Gene Ther. 10(5) 787–800.

    PubMed  CAS  Google Scholar 

  • Kaspar B. K., Llado I., Sherkat N., Rothstein J. D., and Gage F. H. (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301(5634), 839–842.

    PubMed  CAS  Google Scholar 

  • Kay M. A., Manno C. S., Ragni M. V. et al., (2000) Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. 24(3) 257–261.

    PubMed  CAS  Google Scholar 

  • Khajavi M., et al. (2005) Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants. Am. J. Hum. Genet. 77(5) 841–850. Epub 2005 Sep 30.

    PubMed  CAS  Google Scholar 

  • Kochanek S., Clemens P. R., Mitani K. Chen H. H., Chan S., and Caskey C. T. (1996). A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. NAtl Acad Sci USA 93(12) 5731–5736.

    PubMed  CAS  Google Scholar 

  • Kordower J. H., Emborg M. E., Bloch J., et al. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson disease. Science 290(5492), 767–773.

    PubMed  CAS  Google Scholar 

  • Krajewski K. M., Lewis R. A., Fuerst D. R., et al. (2000) Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123(Pt 7), 1516–1527.

    PubMed  Google Scholar 

  • kretz A., Happold C. J., Marticke J. K., and Isenmann S. (2005) Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol. Cell Neurosci. 29(4), 569–579.

    PubMed  CAS  Google Scholar 

  • Kumar-Singh R. and chamberlain J. S. (1996). Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum Mol Genet 5(7):913–922.

    PubMed  CAS  Google Scholar 

  • LeDouarin N. M. and Dupin E. (1993) Cell lineage analysis in neural crest ontogeny. J. Neurobiol. 24, 146–161.

    CAS  Google Scholar 

  • Lemke G. (1996) Neuregulins in development. Mol. Cell Neurosci. 7(4), 247–262.

    PubMed  CAS  Google Scholar 

  • Leone P., Janson C. G., Bilaniuk L., et al. (2000) Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann. Neurol. 48(1), 27–38.

    PubMed  CAS  Google Scholar 

  • Lewis R. A., McDermott M., Krajewski K., Herrmann D. N., and Shy M. E. (2005) CMT Neuropathy Score identifies two year progression in CMY1A patients. J. Peripheral Nervous Syst. (Abstr.) 10(Suppl. 1), 52.

    Google Scholar 

  • Li J., Krajewski K., Lewis R. A., and Shy M. E. (2004) Loss-of-function phenotype of hereditary neuropathy with liability to pressure palsies. Muscle Nerve 29(2), 205–210.

    PubMed  Google Scholar 

  • Li X., Gonias S. L., and Campana W. M. (2005) Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury. Glia 51(4), 254–265.

    PubMed  Google Scholar 

  • Liu Y., Himes B. T., Solowska J., et al. (1999) Intraspinal delivery of neurotrophin-3 using neuralstem cells genetically modified by recombinant retrovirus. Exp. Neurol. 158(1), 9–26.

    PubMed  CAS  Google Scholar 

  • Lupski J. R., de Oca-Luna R. M., Slaugenhaupt S., et al. (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66(2), 219–232.

    PubMed  CAS  Google Scholar 

  • Magyar J. P., Martini R., Ruelicke, et al. (1996) Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16(17), 5351–5360.

    PubMed  CAS  Google Scholar 

  • Manabe Y., Nagano I., Gazi M. S., et al. (2002) Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis. Apoptosis 7(4), 329–334.

    PubMed  CAS  Google Scholar 

  • Massicotte C. and Scherer S. S. (2004) Neuropathies—Translating Causes into Treatments. In: Waxman S. G. (ed.) Neuroscience, Molecular Medicine, and the Therapeutic Transformation of Neurology. Elsevier Science, London, pp. 401–414.

    Google Scholar 

  • Mazarakis N. D., Azzouz M., Rohll J. B., et al. (2001) Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10(19), 2109–2121.

    PubMed  CAS  Google Scholar 

  • McArthur J. C., Yiannoutsos C., Simpson D. M., et al. (2000) A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology 54(5), 1080–1088.

    PubMed  CAS  Google Scholar 

  • Mirsky R. and Jessen K. R. (1996) Schwann cell development, differentiation and myelination. Curr. Opin. Neurobiol. 61(1), 89–96.

    Google Scholar 

  • Mitrophanous K., Yoon S., Rohll, et al. (1999) Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6(11), 1808–1818.

    PubMed  CAS  Google Scholar 

  • Moreira M. C., Klur S., Watanabe M., et al. (2004) Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat. Genet. 36(3), 225–227. Epub 2004 Feb 8.

    PubMed  CAS  Google Scholar 

  • Naldini L., Blomer U., Gage F. H., Trono D., and Verma I. M. (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93(21), 11,382–11,388.

    CAS  Google Scholar 

  • Naldini L., Blomer U., Gallay P., et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272(5259), 263–267.

    PubMed  CAS  Google Scholar 

  • Navon R., Seifried B., Gal-On N. S., and Sadeh M. (1996) A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe de novo Charcot-Marie-Tooth disease. Hum. Genet. 97(5), 685–687.

    PubMed  CAS  Google Scholar 

  • Nishimura A. L., Mitne-Neto M., Silva H. C., et al. (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75(5), 822–831. Epub 2004 Sep 15.

    PubMed  CAS  Google Scholar 

  • Ogilvie C. M., Braude P. R., and Scriven P. N. (2005) Preimplantation genetic diagnosis—an overview. J. Histochem. Cytochem. 53(3), 255–260.

    PubMed  CAS  Google Scholar 

  • Okado-Matsumoto A. and Fridovich I. (2001) Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu, Zn-SOD in mitochondria. J. Biol. Chem. 276(42), 38,388–38,393. Epub 2001 Aug. 15.

    CAS  Google Scholar 

  • Pareek S., Notterpek L., Snipes G. J., et al. (1997) Neurons promote the translocation of peripheral myelin protein 22 into myelin. J. Neurosci. 17(20), 7754–7762.

    PubMed  CAS  Google Scholar 

  • Pasinelli P., Belford M. E., Lennon N., et al. (2004) Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43(1), 19–30.

    PubMed  CAS  Google Scholar 

  • Passage E., Norreel J. C., Noack-Fraissignes P., et al. (2004) Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med. 10(4), 396–401. Epub 2004 Mar 21.

    PubMed  CAS  Google Scholar 

  • Pedrola L., Espert A., Wu X., Claramunt R., Shy M. E., and Palau F. (2005) GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. Hum. Mol. Genet. 14(8), 1087–1094.

    PubMed  CAS  Google Scholar 

  • Pitt M., Houlden H., Jacobs J., et al. (2003) Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. Brain 126(Pt 12), 2682–2692. Epub 2003 Sep 23.

    PubMed  Google Scholar 

  • Pradat P. F. (2003) Treatment of peripheral neuropathies with neutrotrophic factors: animal models and clinical trials. Rev. Neurol. (Paris) 159(2), 147–161.

    CAS  Google Scholar 

  • Puls I., Jonnakuty C., LaMonte B. H., et al. (2003) Mutant dynactin in motor neuron disease. Nat. Genet. 33(4), 455–456.

    PubMed  CAS  Google Scholar 

  • Rabinowitz J. E., Rolling F., Li C., et al. (2002) Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76(2), 791–801.

    PubMed  CAS  Google Scholar 

  • Raeymaekers P., Timmerman V., Nelis E., et al. (1991) Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a) The HMSN Collaborative Research Group. Neuromuscul. Disord. 1(2), 93–97.

    PubMed  CAS  Google Scholar 

  • Reid E., Kloos M., Ashley-Koch A., et al. (2002) Akinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am. J. Hum. Genet. 71(5), 1189–1194. Epub 2002 Sep 24.

    PubMed  CAS  Google Scholar 

  • Roa B. B., Garcia C. A., Suter U., et al. (1993) Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N. Engl. J. Med. 329(2), 96–101.

    PubMed  CAS  Google Scholar 

  • Roussy G. and Levy G. (1926) A sept cas d'une maladie familiale particulaire. Rev. Neurol. 33, 427–450.

    Google Scholar 

  • Russell J. W., Windebank A. J., and Harper C. M. (1995) Treatment of stable chronic demyelinating polyneuropathy with 3,4-diaminopyridine. Mayo Clin. Proc. 70(6), 532–539.

    PubMed  CAS  Google Scholar 

  • Rutledge E. A., Halbert C. L., and Russell D. W. (1998). Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72(1), 309–319.

    PubMed  CAS  Google Scholar 

  • Sahenk Z., Nagaraja H. N., McCracken B. S., et al. (2005) Neurotrophin-3 Promotes Nerve Regeneration and Improvements in sensory function in CMT1A Results from animal models and a pilot clinical study. Neurology 65, 681–685.

    PubMed  CAS  Google Scholar 

  • Salzer J. L. (2003) Polarized domains of myelinated axons. Neuron 40(2), 297–318.

    PubMed  CAS  Google Scholar 

  • Scherer L. and Rossi J. J. (2004) Recent applications of RNAi in mammalian systems. Curr. Pharm. Biotechnol. 5(4), 355–360.

    PubMed  CAS  Google Scholar 

  • Scherer S. S. (1997) The biology and pathobiology of Schwann cells. Curr. Opin. Neurol. 10(5), 386–397.

    PubMed  CAS  Google Scholar 

  • Sereda M., Griffiths I., Puhlhofer, et at. (1996) A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16(5), 1049–1060.

    PubMed  CAS  Google Scholar 

  • Sereda M. W., Meyer Zu Horste G., Suter U., Uzma N., and Nave K. A. (2003) Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) Nat. Med. 9(12), 1533–1537.

    PubMed  CAS  Google Scholar 

  • Shames I., Fraser A., Colby J., Orfali W., and Snipes G. J. (2003) Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases. J. Neuropathol. Exp. Neurol. 62(7), 751–764.

    PubMed  CAS  Google Scholar 

  • Shy M. E., Blake J., Krajewski K., et al. (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64(7), 1209–1214.

    PubMed  CAS  Google Scholar 

  • Shy M. E., and Rose M. R., (2005) Charcot Marie Tooth disease impairs quality of life but why? (and how do we improve it?), Editorial. Neurology 65, 790–791.

    PubMed  Google Scholar 

  • Shy M. E., Tani M., Shi Y. J., et al. (1995) An adenoviral vector can transfer lacZ expression into Schwann cells in culture and in sciatic nerve. Ann. Neurol. 38(3), 429–436.

    PubMed  CAS  Google Scholar 

  • Sorensen J., Haase G., Krarup C., Gilgenkrantz H., Kahn A., and Schmalbruch H. (1998) Gene transfer to Schwann cells after peripheral nerve injury: a delivery system for therapeutic agents. Ann. Neurol. 43(2), 205–211.

    PubMed  CAS  Google Scholar 

  • Southwood C. M., Garbern J., Jiang W., and Gow A. (2002) The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36(4), 585–596.

    PubMed  CAS  Google Scholar 

  • Street V. A., Bennett C. L., Goldy J. D., et al. (2003) Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 60(1), 22–26.

    PubMed  CAS  Google Scholar 

  • Sun L., Li J., and Xiao X. (2000) Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat. Med. 6(5), 599–602.

    PubMed  CAS  Google Scholar 

  • Suter U., Moskow J. J., Welcher A. A., et al. (1992) A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc. Natl. Acad. Sci. USA 89(10), 4382–4386.

    PubMed  CAS  Google Scholar 

  • Suter U. and Scherer S. S. (2003) Disease mechanisms in inherited neuropathies. Nat. Rev. Neurosci. 4(9), 714–726.

    PubMed  CAS  Google Scholar 

  • Suter U., Welcher A. A., Ozcelik T., et al. (1992) Trembler mouse carries a point mutation in a myelin gene. Nature 356(6366), 241–244.

    PubMed  CAS  Google Scholar 

  • Thomas P. K., Marques W., Davis M. B., et al. (1997) The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 120(Pt 3), 465–478.

    PubMed  Google Scholar 

  • Tobler A. R., Notterpek L., Naef R., Taylor V., Suter U., and Shooter E. M. (1999) Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction. J Neurosci. 19(6), 2027–2036.

    PubMed  CAS  Google Scholar 

  • Tooth H. (1886) The Peroneal Type of Progressive Muscular Atrophy. Lewis, London.

    Google Scholar 

  • Trono D. (2000) HIV-based vectors: getting the best out of the worst. J. Gene Med. 2(1), 61–63.

    PubMed  CAS  Google Scholar 

  • Valentijn L. J., Bass F., Wolterman R. A., et al. (1992) Identical point mutations of PMP-22 in Trembler-J mouse and Charcot- Marie-Tooth disease type 1A. Nat. Genet. 2(4), 288–291.

    PubMed  CAS  Google Scholar 

  • Vallat J. M., Sindou P., Preux P. M., et al. (1996) Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann. Neurol. 39(6), 813–817.

    PubMed  CAS  Google Scholar 

  • Vinci P. A., Serrao M., Millul A., et al. (2005) Quality of life in patients with Charcot Marie Tooth disease. Neurology 65, 922–924.

    PubMed  CAS  Google Scholar 

  • Wang X. D., Tang J. G., Xie X. L., et al. (2005) A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporation. J. Gene Med. 3, 1235–1245.

    Google Scholar 

  • Watson D. J., Kobinger G. P., Passini M. A., Wilson J. M., and Wolfe J. H. (2002) Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol. Ther. 5(5 Pt 1), 528–537.

    PubMed  CAS  Google Scholar 

  • Waxman S. G. and Bangalore L. (2004) Electrophysiologic consequences of myelination. In: Lazzarini R. A. (ed.), Myelin biology and disorders. Elsevier, London, vol. 1, pp. 117–143.

    Google Scholar 

  • Webster H. (1993) Development of peripheral nerve fibers. In: Dyck P. J., P. K. T., Low P. A. and Poduslo J. F.. Peripheral Neuropathy. W. B. Saunders, Philadelphia, PA, 243–266.

    Google Scholar 

  • Weimer L. H. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth Disease. J. Neurol. Sci., in press.

  • Xiao C. H., Roberts E. A., Her L. S., et al. (2003) Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J. Cell Biol. 161(1), 55–66. Epub 2003 Apr 7.

    Google Scholar 

  • Xiao X. (2002) Adeno-associated Viruses. Encyclopedia of Life Sciences. Macmillan Publishers Ltd., Nature Publishing Group/www.els.net: 1–9.

  • Xiao X., Li J., and Samulski R. J. (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72(3), 2224–2232.

    PubMed  CAS  Google Scholar 

  • Yamada M., Natsume A., Mata M., et al. (2001) Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion. Exp. Neurol. 168(2), 225–230.

    PubMed  CAS  Google Scholar 

  • Yang J., Dai C., and Liu Y. (2001) Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Gene Ther. 8(19), 1470–1479.

    PubMed  CAS  Google Scholar 

  • Yuen E. C. (2001) The role of neurotrophic factors in disorders of peripheral nerves and motor neurons Phys. Med. Rehabil. Clin. N. Am. 12(2), 293–306, viii

    PubMed  CAS  Google Scholar 

  • Zolotukhin S., Potter M., Zolotukhin, et al. (2002) Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28(2), 158–167.

    PubMed  CAS  Google Scholar 

  • Zuchner S., Mersiyanova I. V., Muglia M., et al. (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36(5), 449–451. Epub. 2004 Apr 4.

    PubMed  Google Scholar 

  • Zuchner S. and Vance J. M. (2005) Emerging pathways for hereditary axonopathies. J. Mol. Med. 83, 935–943.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, 48201, Detroit, MI, USA

    Michael E. Shy

Authors
  1. Michael E. Shy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael E. Shy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shy, M.E. Therapeutic strategies for the inherited neuropathies. Neuromol Med 8, 255–278 (2006). https://doi.org/10.1385/NMM:8:1-2:255

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1385/NMM:8:1-2:255

Index Entries

Search

Navigation